Artiva to Suspend Cell Therapy After Two Patient Deaths, Cut Staff 94%
Artiva will suspend its cell therapy program after two patient deaths and reduce its workforce by 94%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.